Public HealthNorth American Launch For Revolutionary DrainPRO™ Protects Against Hospital & Community Acquired Infections
LAMAL USA today announced the long-awaited North American launch
of DrainPRO™ at the Association for Professionals in Infection Control and Epidemiology
(APIC) conference in Fort Lauderdale, June 8th. A patented, antimicrobial-infused drain
insert, DrainPRO™ blocks infection causing bacteria, odors and insects from entering
health care and other clean environments.
"We"ve been waiting a long time for an infection control product as simple and effective
as DrainPRO™" said Bernie Lyons, National Risk and Quality Manager with Healthe
Care Australia in Sydney. "Drain openings are bacteria hot spots. With the skyrocketing
frequency of hospital acquired infections, we have to be sure we"re sanitizing every
single infection including drains - especially drains."
Lawrence Evans, DrainPRO"s Australian designer added: "Drain openings are a breeding
ground for deadly superbugs like MRSA and are a of foul odors. I designed
DrainPRO to seal drains while maximizing water flow. The units are infused with
MicrobePRO™ antimicrobial agent and have been tested and certified to be 99.99%
effective against a comprehensive range of bacteria."
Since 2007 when the deaths of 6 babies in a Canadian hospital were blamed on
Pseudomonas aeruginosa in drainsÂð, infection control experts have struggled with the
problem of sanitizing hospital drains. Harsh chemicals provide a temporary fix but are
harmful to the environment. Sealing drains AND killing bacteria without blocking full
water flow was Evans" design goal. The result, his patented DrainPRO™, is now being
used in Australian hospitals.
DrainPRO™ is part of the MicrobePRO™ suite of infection control solutions
manufactured and distributed by LAMAL Group Pty Ltd. headquartered in Brisbane,
Australia.
Âð Reuters Health eLine - 2007-04-27
LAMAL USA